These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 31914678

  • 1. The HDAC3 inhibitor RGFP966 ameliorated ischemic brain damage by downregulating the AIM2 inflammasome.
    Zhang MJ, Zhao QC, Xia MX, Chen J, Chen YT, Cao X, Liu Y, Yuan ZQ, Wang XY, Xu Y.
    FASEB J; 2020 Jan; 34(1):648-662. PubMed ID: 31914678
    [Abstract] [Full Text] [Related]

  • 2. Proteomic Analysis of HDAC3 Selective Inhibitor in the Regulation of Inflammatory Response of Primary Microglia.
    Xia M, Zhao Q, Zhang H, Chen Y, Yuan Z, Xu Y, Zhang M.
    Neural Plast; 2017 Jan; 2017():6237351. PubMed ID: 28293439
    [Abstract] [Full Text] [Related]

  • 3. Targeting HDAC3 Activity with RGFP966 Protects Against Retinal Ganglion Cell Nuclear Atrophy and Apoptosis After Optic Nerve Injury.
    Schmitt HM, Schlamp CL, Nickells RW.
    J Ocul Pharmacol Ther; 2018 Apr; 34(3):260-273. PubMed ID: 29211617
    [Abstract] [Full Text] [Related]

  • 4. HDAC3 promotes pulmonary fibrosis by activating NOTCH1 and STAT1 signaling and up-regulating inflammasome components AIM2 and ASC.
    Zheng Q, Lei Y, Hui S, Tong M, Liang L.
    Cytokine; 2022 May; 153():155842. PubMed ID: 35306425
    [Abstract] [Full Text] [Related]

  • 5. Histone deacetylase 3-selective inhibitor RGFP966 ameliorates impaired glucose tolerance through β-cell protection.
    Lei L, Bai G, Wang X, Liu S, Xia J, Wu S, Huan Y, Shen Z.
    Toxicol Appl Pharmacol; 2020 Nov 01; 406():115189. PubMed ID: 32800772
    [Abstract] [Full Text] [Related]

  • 6. Pterostilbene improves neurological dysfunction and neuroinflammation after ischaemic stroke via HDAC3/Nrf1-mediated microglial activation.
    Chen Y, He W, Qiu J, Luo Y, Jiang C, Zhao F, Wei H, Meng J, Long T, Zhang X, Yang L, Xu Q, Wang J, Zhang C.
    Cell Mol Biol Lett; 2024 Aug 28; 29(1):114. PubMed ID: 39198723
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. HDAC3 inhibitor RGFP966 controls bacterial growth and modulates macrophage signaling during Mycobacterium tuberculosis infection.
    Campo M, Heater S, Peterson GJ, Simmons JD, Skerrett SJ, Mayanja-Kizza H, Stein CM, Boom WH, Hawn TR.
    Tuberculosis (Edinb); 2021 Mar 28; 127():102062. PubMed ID: 33639591
    [Abstract] [Full Text] [Related]

  • 9. The Effects of Pharmacological Inhibition of Histone Deacetylase 3 (HDAC3) in Huntington's Disease Mice.
    Jia H, Wang Y, Morris CD, Jacques V, Gottesfeld JM, Rusche JR, Thomas EA.
    PLoS One; 2016 Mar 28; 11(3):e0152498. PubMed ID: 27031333
    [Abstract] [Full Text] [Related]

  • 10. HDAC3 Inhibitor RGFP966 Ameliorated Neuroinflammation in the Cuprizone-Induced Demyelinating Mouse Model and LPS-Stimulated BV2 Cells by Downregulating the P2X7R/STAT3/NF-κB65/NLRP3 Activation.
    Sun W, Zhang N, Liu B, Yang J, Loers G, Siebert HC, Wen M, Zheng X, Wang Z, Han J, Zhang R.
    ACS Chem Neurosci; 2022 Sep 07; 13(17):2579-2598. PubMed ID: 35947794
    [Abstract] [Full Text] [Related]

  • 11. RGFP966 is protective against lipopolysaccharide-induced depressive-like behaviors in mice by inhibiting neuroinflammation and microglial activation.
    Bian HT, Xiao L, Liang L, Xie YP, Wang HL, Wang GH.
    Int Immunopharmacol; 2021 Dec 07; 101(Pt B):108259. PubMed ID: 34666303
    [Abstract] [Full Text] [Related]

  • 12. RGFP966, a selective HDAC3 inhibitor, ameliorates allergic and inflammatory responses in an OVA-induced allergic rhinitis mouse model.
    Zhang W, Sun X, Ba G, Tang R, Lin H.
    Int Immunopharmacol; 2021 Apr 07; 93():107400. PubMed ID: 33529911
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inhibition of HDAC3 prevents diabetic cardiomyopathy in OVE26 mice via epigenetic regulation of DUSP5-ERK1/2 pathway.
    Xu Z, Tong Q, Zhang Z, Wang S, Zheng Y, Liu Q, Qian LB, Chen SY, Sun J, Cai L.
    Clin Sci (Lond); 2017 Aug 01; 131(15):1841-1857. PubMed ID: 28533215
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. HDAC3 inhibitor suppresses endothelial-to-mesenchymal transition via modulating inflammatory response in atherosclerosis.
    Chen L, Shang C, Wang B, Wang G, Jin Z, Yao F, Yue Z, Bai L, Wang R, Zhao S, Liu E, Wang W.
    Biochem Pharmacol; 2021 Oct 01; 192():114716. PubMed ID: 34339713
    [Abstract] [Full Text] [Related]

  • 18. A selective inhibitor of histone deacetylase 3 prevents cognitive deficits and suppresses striatal CAG repeat expansions in Huntington's disease mice.
    Suelves N, Kirkham-McCarthy L, Lahue RS, Ginés S.
    Sci Rep; 2017 Jul 20; 7(1):6082. PubMed ID: 28729730
    [Abstract] [Full Text] [Related]

  • 19. RGFP966, a histone deacetylase 3 inhibitor, promotes glioma stem cell differentiation by blocking TGF-β signaling via SMAD7.
    Liang H, Wang Q, Wang D, Zheng H, Kalvakolanu DV, Lu H, Wen N, Chen X, Xu L, Ren J, Guo B, Zhang L.
    Biochem Pharmacol; 2020 Oct 20; 180():114118. PubMed ID: 32585142
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.